Form D Explorer
Hemanext Inc. · CIK 1305849

Report a data issueCitable research briefCompare issuerPrivate research collection

Hemanext Inc.

CIK 1305849 · Corporation · Inc. DELAWARE · LEXINGTON, Massachusetts · Other Health Care

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
2
Amendments
0
Activity
Jul 31, 2025
through Aug 5, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldJul 31, 2025 · DAug 5, 2025 · DLater minus earlier
Reported offering amount$21,714,277$24,000,000$2,285,723
Reported amount sold$21,714,277$19,978,442$-1,735,835
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001305849-25-000004 · Later SEC source: 0001305849-25-000005

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Aug 5, 2025

Reported offering amount
$24,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$19,978,442

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)